Evolus, Inc. (EOLS)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$6.00
-3.62%
Mkt Cap $393.81M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$15.00
Range $13.00 – $17.00
Implied Upside
+150.2%
Consensus $15.00 vs current $6.00